Bio-Rad falls after Q4 profit miss

Bio-Rad Laboratories

13/02/2026 13:51

** Shares of life sciences firm Bio-Rad Laboratories BIO.N plunge 15.3% to $247.75 premarket

** Co on Wednesday reported Q4 adjusted profit per share of $2.51, below LSEG-compiled analysts' average estimate of $2.70

** However, revenue of $693.2 million beat analysts' average expectation of $688.76 million

** Quarterly sales in the life-science segment fell 2.6% year-on-year to $267.9 million, due to constrained academic research and biotech funding

** Up to last close, stock was down 3.5% YTD

 (Reporting by Christy Santhosh in Bengaluru)

 ((Christy.Santhosh@thomsonreuters.com))